Edwards Lifesciences Corp (NYSE:EW) - Share price - Overview

Stock Report

Edwards Lifesciences Corp EW

Last Price
$111.20

Day Change
1.15|1.04%

As of 18/10/2017
16:35:48 EDT | USD
Minimum 15 Minutes Delay.

Last Close110.05
Day Range110.06 - 111.43
Mkt Cap23.48Bil
52-Wk Range81.12 - 121.45
Yield %-
ISINUS28176E1082
Volume865,675
P/E33.70
P/S7.47
P/CF32.93

Share Price

Financials
201420152016
More ...
Income Statement
Revenue2,322.902,493.702,963.70
Operating Income1,233.20635.70785.70
Net Income811.10494.90569.50
Basic EPS3.812.302.67
Avg. Diluted Shares Outstanding217220218
Balance Sheet
Current Assets2,294.602,047.902,240.00
Non Current Assets1,229.702,011.402,270.00
Total Assets3,524.304,059.304,510.00
Current Liabilities434.40476.20532.50
Total Liabilities1,332.901,556.201,891.00
Total Equity2,191.402,503.102,619.00
Cash Flow
Operating Cash Flow1,022.30549.70704.40
Capital Expenditure-93.70-106.50-217.40
Free Cash Flow928.60443.20487.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

11,100
Key Stats
More ...
Price/Earning TTM32.66
Price/Book7.91
Price/Sales TTM7.39
Rev Growth (3 year avg)13.16
EPS Growth (3 year avg)-
Operating Margin % TTM26.51
Net Margin % TTM19.22
ROE TTM22.24
Debt/Equity0.31
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.